Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016
- PMID: 30217407
- DOI: 10.1016/j.ypmed.2018.09.001
Correlations between population-levels of prescription opioid dispensing and related deaths in Ontario (Canada), 2005-2016
Abstract
Canada is experiencing an ongoing opioid-related public health crisis, including persistently rising opioid (e.g., poisoning) mortality. Previous research has documented marked correlations between population-levels of opioid dispensing and deaths. We examined possible correlations between annual population-level dispensing of specific opioid formulations and related poisoning deaths in Ontario (Canada), for the period 2005-2016. Annual coroner statistics-based numbers of poisoning deaths associated with six main opioid formulations (codeine, fentanyl, hydromorphone, methadone, morphine, and oxycodone) for Ontario were converted into annual death rates (per 100,000 population). Annual dispensing data for the opioid formulations under study were based on commercial retail-sales data from a representative, stratified sample of community pharmacies (IMSQuintiles/IQVIA CompuScript), converted into Defined Daily Doses (DDD/1,000 population/day). Possible relationships between the annual death and dispensing rates were assessed by Pearson's correlation coefficient analyses. Death rates increased for almost all, while dispensing rates increased for half of the opioid categories. A significant positive correlation between death and dispensing rates was found for hydromorphone (r = 0.97, 95% CI: 0.88-0.99) and oxycodone (r = 0.90, 95% CI: 0.68-0.97) formulations; a significant negative correlation was found for codeine (r = -0.78, 95% CI: -0.93 to -0.37). No significant correlations were detected for fentanyl, methadone, and morphine related deaths. Strong correlations between levels of dispensing and deaths for select opioid formulations were found. For select others, extrinsic factors - e.g., increasing involvement of non-medical opioid products (e.g., fentanyl) in overdose deaths - likely confounded underlying correlation effects. Opioid dispensing levels continue to influence population-level mortality levels, and need to be addressed by prevention strategies.
Keywords: Canada; Dispensing; Mortality; Ontario; Opioids; Population; Prescribing.
Copyright © 2018. Published by Elsevier Inc.
Similar articles
-
Patterns, Changes, and Trends in Prescription Opioid Dispensing in Canada, 2005-2016.Pain Physician. 2018 May;21(3):219-228. Pain Physician. 2018. PMID: 29871366
-
Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005-2011.Drug Alcohol Rev. 2014 Jan;33(1):19-26. doi: 10.1111/dar.12089. Epub 2013 Nov 21. Drug Alcohol Rev. 2014. PMID: 24261474
-
High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009.Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):438-42. doi: 10.1002/pds.3404. Epub 2013 Jan 14. Pharmacoepidemiol Drug Saf. 2013. PMID: 23319301
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
An overview of the patterns of prescription opioid use, costs and related harms in Australia.Br J Clin Pharmacol. 2014 Nov;78(5):1159-66. doi: 10.1111/bcp.12446. Br J Clin Pharmacol. 2014. PMID: 24962372 Free PMC article. Review.
Cited by
-
Individualized Prospective Prediction of Opioid Use Disorder.Can J Psychiatry. 2023 Jan;68(1):54-63. doi: 10.1177/07067437221114094. Epub 2022 Jul 26. Can J Psychiatry. 2023. PMID: 35892186 Free PMC article.
-
Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators.Subst Abuse Treat Prev Policy. 2021 Jan 26;16(1):12. doi: 10.1186/s13011-021-00348-z. Subst Abuse Treat Prev Policy. 2021. PMID: 33499891 Free PMC article. Review.
-
Income-Based Disparities in Opioid Prescription Dispensing Among Public Drug Plan Beneficiaries in Canada from 2010 to 2018: A Population-Based and Sex-Stratified Retrospective Study.Drugs Real World Outcomes. 2025 Sep;12(3):337-349. doi: 10.1007/s40801-025-00498-7. Epub 2025 May 30. Drugs Real World Outcomes. 2025. PMID: 40445549 Free PMC article.
-
Nonmedical Prescription Opioid Use among a Sample of College Students: Prevalence and Predictors.Pharmacy (Basel). 2021 May 28;9(2):106. doi: 10.3390/pharmacy9020106. Pharmacy (Basel). 2021. PMID: 34071670 Free PMC article.
-
Trends and correlated outcomes in population-level prescription opioid and transdermal fentanyl use in Israel.Isr J Health Policy Res. 2023 Mar 20;12(1):9. doi: 10.1186/s13584-023-00558-9. Isr J Health Policy Res. 2023. PMID: 36941731 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials